Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mansi Khande"'
Autor:
Vanita Noronha, Atul Budukh, Pankaj Chaturvedi, Srikanth Anne, Anshu Punjabi, Maheema Bhaskar, Tarini P. Sahoo, Nandini Menon, Minit Shah, Ullas Batra, Shrinidhi Nathany, Rajiv Kumar, Omshree Shetty, Trupti Pai Ghodke, Abhishek Mahajan, Nivedita Chakrabarty, Supriya Hait, Satyendra C. Tripathi, Anuradha Chougule, Pratik Chandrani, Virendra Kumar Tripathi, Sabita Jiwnani, Anil Tibdewal, Guncha Maheshwari, Rushabh Kothari, Vijay M. Patil, Rajani Surendar Bhat, Mansi Khanderia, Vandana Mahajan, Ravi Prakash, Sanjeev Sharma, Adnan Abdul Jabbar, Birendra Kumar Yadav, A.F.M. Kamal Uddin, Amit Dutt, Kumar Prabhash
Publikováno v:
The Lancet Regional Health - Southeast Asia, Vol 27, Iss , Pp 100430- (2024)
Summary: Lung cancer varies between Caucasians and Asians. There have been differences recorded in the epidemiology, genomics, standard therapies and outcomes, with variations according to the geography and ethnicity which affect the decision for opt
Externí odkaz:
https://doaj.org/article/92226369dd7a49c297c55f18f82e07aa
Autor:
Mansi Khanderia
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 4, Pp 755-756 (2020)
Externí odkaz:
https://doaj.org/article/5cc16d210115499a927508c84cf89408
Publikováno v:
Journal of Clinical Pediatric Dentistry. 45:406-413
Purpose : To examine the cytotoxicity and genetic expression of SHEDs cultured in eluates of various calcium silicate based pulpotomy materials. Study design : MTT assay, flow cytometry, alizarin red staining and scratch assay was used to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f19b2fef323dd7c7b2f3e6a78958d5
https://doi.org/10.17796/1053-4625-45.6.7
https://doi.org/10.17796/1053-4625-45.6.7
Autor:
BJ Srinivasa, Bhanu Prakash Lalkota, Girish Badarke, Diganta Hazarika, Nasiruddin Mohammad, Sulav Sapkota, Mansi Khanderia, D Tousif, Raghavendra Rao, Amritanshu Ram, Shekar Patil, Radheshyam Naik
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 12 (2018)
Background: Eribulin mesylate is a non-taxane microtubule inhibitor which can be used after anthracycline and taxane treatment in patients with metastatic breast cancer (MBC). The purpose of this study was to investigate the efficacy and safety of er
Externí odkaz:
https://doaj.org/article/17d9df9007f0458e8761743c698fc60d
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 2, Pp 263-264 (2019)
Externí odkaz:
https://doaj.org/article/4513b69cd46948e2a00fe971716274d2
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 2, Pp 271-272 (2019)
Externí odkaz:
https://doaj.org/article/820f550642974135a5a53768dcab4b42